Datasets:
tahasawan
/
Health_Dataset

Dataset card Data Studio Files
xet
 Community
2
Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Italy
2,013
Malaria
Respiratory
0.95
1.55
8.42
0-18
Male
471,007
57.74
3.34
7.58
Medication
21,064
No
91.82
4,493
2.16
16,886
0.79
86.02
France
2,002
Ebola
Parasitic
12.46
8.63
8.75
61+
Male
634,318
89.21
1.33
5.11
Surgery
47,851
Yes
76.65
2,366
4.82
80,639
0.74
45.52
Turkey
2,015
COVID-19
Genetic
0.91
2.35
6.22
36-60
Male
154,878
56.41
4.07
3.49
Vaccination
27,834
Yes
98.55
41
5.81
12,245
0.41
40.2
Indonesia
2,011
Parkinson's Disease
Autoimmune
4.68
6.29
3.99
0-18
Other
446,224
85.2
3.18
8.44
Surgery
144
Yes
67.35
3,201
2.22
49,336
0.49
58.47
Italy
2,013
Tuberculosis
Genetic
0.83
13.59
7.01
61+
Male
472,908
67
4.61
5.9
Medication
8,908
Yes
50.06
2,832
6.93
47,701
0.5
48.14
Saudi Arabia
2,011
Dengue
Bacterial
10.99
6.49
4.64
61+
Female
479,234
98.41
3.5
0.62
Therapy
42,671
Yes
93.17
416
9.83
29,597
0.46
56.5
USA
2,013
Malaria
Cardiovascular
18.42
6.33
9.33
61+
Female
289,931
90.03
3.16
3.31
Surgery
15,579
No
92.8
4,535
0.89
60,027
0.7
20.48
Nigeria
2,007
Tuberculosis
Neurological
3.48
5.71
1.21
0-18
Female
393,296
75.6
0.54
3.54
Medication
15,744
Yes
65.45
4,584
9.81
23,222
0.46
66.49
Italy
2,000
Rabies
Chronic
15.59
4.74
6.38
19-35
Female
253,110
87.87
4.56
5.84
Therapy
7,669
Yes
59.23
2,253
9.92
30,849
0.55
41.27
Australia
2,006
Cholera
Chronic
10.12
2.08
6
61+
Male
174,143
95.9
4.63
6.01
Medication
9,468
Yes
93.21
4,694
2.96
68,856
0.9
83.3
Canada
2,011
Leprosy
Cardiovascular
11.15
0.6
2.97
36-60
Female
76,858
67.88
0.66
1.99
Surgery
19,993
Yes
76.16
4,238
1.23
44,699
0.58
51.5
Mexico
2,009
Cancer
Metabolic
3.88
10.85
1.85
0-18
Male
462,950
71.06
4.08
6.22
Vaccination
36,202
Yes
63.54
2,797
3.16
30,015
0.61
29.05
Nigeria
2,007
Diabetes
Infectious
8.92
13.19
5.52
36-60
Female
227,849
84.41
1.37
9.57
Therapy
45,685
No
68.02
423
3.98
60,608
0.61
68.17
France
2,004
Measles
Bacterial
11.4
5.15
7.77
61+
Male
420,730
86.28
4.73
0.73
Therapy
49,545
Yes
52.4
968
1.11
64,119
0.59
63.84
Australia
2,020
Zika
Parasitic
17.27
1.26
7.08
61+
Male
766,425
53.75
3.15
8.49
Therapy
20,169
Yes
58.19
3,731
4.51
48,701
0.83
26.05
USA
2,024
Dengue
Viral
1.82
2.98
7.01
36-60
Female
623,844
96.83
0.56
9.72
Medication
4,664
No
87.75
484
8.11
56,179
0.63
29
Nigeria
2,009
Leprosy
Parasitic
15.18
14.95
8.21
0-18
Male
788,926
87.33
3.96
4.49
Vaccination
31,596
Yes
50.8
2,773
0.79
6,053
0.41
31.82
Australia
2,006
Alzheimer's Disease
Bacterial
13.39
13.85
4.04
61+
Male
134,472
90.34
2.8
6.73
Surgery
44,696
Yes
58.67
3,088
5.51
23,813
0.87
57.71
France
2,015
Polio
Respiratory
14.44
5.69
2.21
19-35
Other
959,930
57.31
2.93
6.93
Medication
48,221
Yes
54.8
1,537
6.49
99,481
0.84
28.24
Indonesia
2,001
Hypertension
Cardiovascular
3.24
0.43
2.12
36-60
Male
938,294
54.07
3.14
9.09
Vaccination
32,325
Yes
92.95
2,110
4.93
86,168
0.79
25.86
Turkey
2,019
Leprosy
Respiratory
8.74
1.42
1.54
19-35
Other
124,225
59.94
0.8
6.22
Vaccination
20,405
No
73.62
2,958
4.22
50,131
0.76
70.77
China
2,001
Ebola
Neurological
2.92
1.17
7.35
36-60
Other
276,364
80.23
2.27
3.57
Surgery
28,401
Yes
51.53
1,742
1.47
8,526
0.4
31.5
South Africa
2,014
Malaria
Bacterial
5.94
4.29
2.36
61+
Female
857,183
61.32
4.56
6.88
Therapy
14,578
Yes
72.97
433
1.4
52,974
0.53
43.97
Japan
2,021
Diabetes
Autoimmune
11.24
4.78
5.68
19-35
Male
947,147
66.78
4.46
1.2
Surgery
20,397
Yes
98.55
4,994
7.43
93,229
0.64
46.04
USA
2,000
Asthma
Metabolic
7.91
9.13
1.58
0-18
Male
365,955
64.87
1.28
4.67
Therapy
8,688
No
79.09
1,480
9.56
85,413
0.4
31.14
UK
2,010
Diabetes
Genetic
10.58
12.3
2.37
0-18
Female
822,231
66.36
1.31
9.32
Surgery
4,533
Yes
52.91
4,187
3.67
3,239
0.52
71.13
Canada
2,001
Tuberculosis
Neurological
16.03
7.29
0.39
61+
Male
804,802
78.96
2.46
7.72
Therapy
1,676
No
80.52
2,653
8.64
60,168
0.45
41.91
Russia
2,003
Measles
Neurological
1.45
12.86
3.21
36-60
Male
468,005
63.31
2.53
1.41
Therapy
12,119
No
90.01
4,128
7.68
19,846
0.9
34.35
Mexico
2,022
Rabies
Neurological
11.63
8.99
0.54
36-60
Other
402,997
90.8
2.36
8.25
Surgery
9,975
No
84.78
3,139
4.71
11,786
0.6
87.24
UK
2,019
Zika
Neurological
14.72
0.84
6.72
0-18
Male
294,143
50
2.23
9.51
Vaccination
26,485
No
66.32
434
6.07
35,741
0.78
82.92
Japan
2,002
Alzheimer's Disease
Respiratory
12.61
12.98
5.45
19-35
Male
116,844
65.71
4.19
9.69
Vaccination
16,118
No
64.88
747
8.59
4,033
0.86
39.69
Saudi Arabia
2,006
Cancer
Parasitic
15.12
9.04
6.9
0-18
Female
834,340
91
3.02
2.05
Therapy
15,983
No
89.49
3,833
6.01
84,531
0.9
80.19
Canada
2,001
Malaria
Autoimmune
13.29
9.76
7.77
0-18
Male
205,610
89.47
3.6
8.46
Medication
1,190
No
67.79
1,989
4.73
50,405
0.89
38.11
Brazil
2,003
Parkinson's Disease
Viral
13.85
4.52
3.23
61+
Male
700,175
62.54
3.25
5.22
Medication
33,734
Yes
75.62
4,468
9.79
11,089
0.48
24.44
Canada
2,019
COVID-19
Bacterial
2.08
12.8
0.1
36-60
Other
558,329
55.52
0.78
6.89
Vaccination
36,659
No
62.21
3,997
6.08
21,921
0.4
25.7
Brazil
2,011
Parkinson's Disease
Neurological
6.42
10.08
0.29
0-18
Other
136,567
50.48
3.07
8.06
Surgery
18,886
Yes
80.2
1,595
5.37
41,181
0.73
25.31
France
2,005
Diabetes
Metabolic
6.09
10.77
1.42
19-35
Other
267,802
95.85
3.42
9.14
Medication
27,027
No
82.82
3,580
9.46
66,816
0.6
48.75
Turkey
2,006
Malaria
Cardiovascular
10.53
2.5
5.09
0-18
Male
923,451
76.24
1.43
2.95
Vaccination
29,311
Yes
93.53
110
6.45
51,865
0.74
58.38
Australia
2,014
HIV/AIDS
Cardiovascular
12.52
3.13
9.14
19-35
Female
828,045
68.61
0.9
8.3
Surgery
41,081
Yes
61.53
2,764
7.16
20,964
0.86
85.65
Japan
2,022
Malaria
Metabolic
3.77
1.02
3
0-18
Male
509,716
63.88
0.57
8.23
Vaccination
49,265
No
51.6
4,416
0.45
7,171
0.48
36.94
France
2,008
Tuberculosis
Respiratory
4.6
4.94
2.08
61+
Female
215,901
63.27
2.44
0.86
Therapy
35,024
Yes
73.99
3,893
0.04
35,337
0.49
80.47
Mexico
2,006
Dengue
Neurological
5.84
6.71
0.63
61+
Other
999,156
95.87
2.02
5.29
Therapy
47,635
Yes
90.72
4,251
3.48
9,033
0.42
72.74
Indonesia
2,000
Rabies
Bacterial
1.22
13.78
3.9
0-18
Male
723,071
56.9
3.04
3.53
Therapy
45,214
Yes
97.84
4,746
3.3
24,147
0.73
79.39
Turkey
2,022
Measles
Chronic
6.97
2.22
6.35
36-60
Male
534,508
91.15
0.62
5.87
Vaccination
24,653
No
76.34
2,649
3.99
17,444
0.5
59.77
Germany
2,017
Cancer
Metabolic
3.04
2.12
4.46
61+
Male
639,082
96.85
1.99
2.73
Medication
33,639
Yes
71.36
3,351
8.09
20,359
0.73
86.25
Brazil
2,003
Alzheimer's Disease
Neurological
12.5
13.27
9.34
19-35
Male
280,906
89.39
3.91
5.6
Surgery
16,622
Yes
87.39
326
1.16
32,806
0.61
70.08
Brazil
2,010
HIV/AIDS
Autoimmune
0.13
13.99
1.46
36-60
Female
134,964
69.35
5
0.55
Vaccination
14,688
Yes
61.6
1,804
7.23
57,996
0.79
42.37
UK
2,003
Malaria
Chronic
1.08
0.18
3.54
61+
Male
596,241
85.86
2.84
5.94
Medication
31,291
No
53.7
3,352
8.65
55,241
0.59
85.04
Australia
2,009
Alzheimer's Disease
Infectious
2.44
8.04
8.74
0-18
Other
283,322
97.18
4.05
5.16
Therapy
26,854
No
93.65
1,398
7.02
49,594
0.71
70.7
Saudi Arabia
2,023
Hypertension
Metabolic
14.72
13.9
3.28
36-60
Female
28,737
97.73
4.51
5.6
Medication
24,176
No
85.19
783
3.9
8,158
0.61
76.37
India
2,003
Alzheimer's Disease
Bacterial
0.19
14.26
8.38
0-18
Male
349,846
72.29
3.1
5.47
Medication
35,329
Yes
81.85
3,788
8.8
91,267
0.58
45.22
Nigeria
2,002
Measles
Neurological
3.49
14
6.61
36-60
Male
786,558
58.08
4.73
3.98
Vaccination
21,612
No
74.02
2,576
9.07
43,869
0.63
40.08
China
2,022
Zika
Metabolic
17.12
4.84
7.71
36-60
Female
343,352
98.3
0.87
7.39
Vaccination
43,779
Yes
84.34
607
7.43
98,415
0.55
37.01
Argentina
2,015
Cholera
Infectious
18.17
12.36
2.68
61+
Male
417,401
78.88
2.77
8.01
Therapy
26,058
No
81.03
1,210
7.43
29,542
0.63
46.32
Argentina
2,024
Cancer
Parasitic
10.94
12.88
6.25
61+
Female
419,192
94.54
1.99
5.36
Medication
16,363
Yes
72.52
1,274
5.36
9,633
0.51
37.11
Italy
2,008
Ebola
Chronic
15.94
11.73
6.37
0-18
Other
644,854
51.11
4.32
5.53
Surgery
17,197
No
74.51
2,835
8.59
33,096
0.4
45.7
Russia
2,019
Dengue
Autoimmune
13.86
0.79
1.18
0-18
Other
251,830
71.56
0.73
0.67
Vaccination
29,568
Yes
52.61
1,731
6.47
12,142
0.63
57.36
USA
2,011
Dengue
Chronic
10.45
11.76
5.57
36-60
Male
87,481
99.11
2.64
1.49
Therapy
33,766
Yes
80.17
393
9.96
56,348
0.65
74.74
Argentina
2,007
Measles
Parasitic
15.6
0.63
7.03
61+
Female
653,664
80.52
1.42
1.64
Vaccination
49,833
No
91.28
3,292
8.75
4,120
0.44
83.11
Russia
2,023
Leprosy
Bacterial
16.22
8.43
9.61
61+
Other
422,327
51.8
3.75
2.98
Therapy
27,605
Yes
98.03
3,145
4.23
13,691
0.79
22.94
China
2,014
Polio
Cardiovascular
0.55
0.85
3.83
36-60
Female
123,270
62.89
1.19
1.36
Vaccination
18,513
Yes
58.47
4,739
4.47
99,993
0.69
26.87
Japan
2,017
Tuberculosis
Genetic
13.63
8.09
7.03
36-60
Male
633,115
55.2
2.62
4.59
Medication
22,954
No
66.11
4,969
0.13
52,433
0.41
65.18
Brazil
2,013
Ebola
Metabolic
16.01
8.55
1.35
19-35
Male
384,573
81.59
3.08
3.16
Medication
18,972
No
70.43
3,356
8.75
14,196
0.81
63.55
Japan
2,005
Influenza
Respiratory
8.6
13.42
2.32
36-60
Female
757,834
82.86
2.72
5.17
Medication
14,207
No
75.42
2,297
3.93
22,316
0.87
27.89
Nigeria
2,010
Diabetes
Cardiovascular
18.17
6.2
2.12
19-35
Female
985,553
88.65
3.82
5.76
Therapy
14,348
No
88.66
1,984
4.35
45,639
0.51
73.39
Russia
2,008
Asthma
Metabolic
1.69
7.96
7.09
0-18
Other
879,623
98.94
1.41
3.93
Surgery
12,685
No
72.26
760
5.6
44,330
0.58
77.15
Nigeria
2,017
HIV/AIDS
Neurological
1.17
10.47
5.72
0-18
Other
368,210
99.1
4.77
6.07
Medication
9,051
No
96.1
4,875
3.73
63,276
0.56
35.5
France
2,006
Ebola
Autoimmune
9.01
3.55
6.53
0-18
Other
773,388
57.54
1.21
6.32
Surgery
2,932
No
64.38
3,280
6.27
74,864
0.54
25.16
South Korea
2,000
Alzheimer's Disease
Genetic
3.96
5.55
0.62
36-60
Male
815,017
80.67
1.09
3
Therapy
42,062
Yes
67.77
800
5.45
91,647
0.45
31.22
Australia
2,024
Measles
Genetic
5.88
12.37
4.73
36-60
Other
767,034
81.29
3.62
6.73
Surgery
33,829
No
75.4
2,921
7.85
50,348
0.87
56.51
South Africa
2,017
Hepatitis
Neurological
10.72
6.64
7.89
0-18
Male
22,434
93.27
1.15
5.08
Therapy
32,840
No
70.46
3,298
7.44
41,156
0.68
41.79
Argentina
2,006
Measles
Infectious
3.95
4
8.84
0-18
Male
116,183
77.08
4.75
6.01
Surgery
22,983
No
64.73
3,375
1.49
27,909
0.76
79.55
USA
2,002
Hepatitis
Respiratory
7.13
6.96
4.02
61+
Other
251,611
53.4
2.28
2.55
Therapy
45,671
Yes
94.23
1,869
1.21
84,905
0.82
88.36
USA
2,012
Diabetes
Chronic
4.9
6.6
6.16
61+
Female
438,583
53.83
1.33
5.89
Surgery
40,367
Yes
95.01
1,674
5.37
48,607
0.74
80.33
Australia
2,017
Cholera
Chronic
6.33
12.84
2.47
36-60
Female
183,029
67.22
0.73
0.72
Therapy
39,219
No
87.03
2,658
3.29
30,332
0.77
23.65
Turkey
2,003
HIV/AIDS
Metabolic
18.56
0.9
7.51
0-18
Female
751,970
92.95
0.89
2.85
Vaccination
25,402
No
78.8
3,688
2.15
57,913
0.64
41.13
India
2,017
Polio
Cardiovascular
1.26
6.79
7.42
36-60
Other
243,846
50.4
2.08
5.39
Medication
9,681
No
60.5
4,084
6.72
56,210
0.56
78.17
India
2,010
Ebola
Genetic
4.21
11
7.01
0-18
Male
656,226
73.58
2.35
2.5
Medication
27,378
Yes
75.42
1,953
4.68
44,096
0.76
84.27
Turkey
2,009
Parkinson's Disease
Parasitic
0.13
4.88
5.56
36-60
Other
928,625
77.83
1.09
7.68
Surgery
16,925
No
92.6
1,011
9.73
4,928
0.56
21.46
Brazil
2,024
Diabetes
Genetic
0.73
9.28
1.09
19-35
Male
4,233
54.43
2.58
3.1
Therapy
2,078
No
61.8
386
3.23
73,287
0.74
25.44
Saudi Arabia
2,013
Zika
Cardiovascular
5.02
12.51
7.95
36-60
Male
438,887
83.75
4.59
2.83
Medication
785
No
60.11
561
7.37
50,267
0.64
34.56
Japan
2,003
Zika
Cardiovascular
8.85
10.11
5.56
61+
Male
176,109
74.09
4.95
4.28
Vaccination
3,231
No
67.02
2,578
4.26
54,291
0.63
45.8
Mexico
2,013
Influenza
Neurological
6.53
3.9
6.61
19-35
Female
845,940
59.02
1.28
6.74
Medication
13,525
No
96.32
4,051
8.44
20,428
0.53
68.48
Germany
2,008
Polio
Metabolic
15.02
0.38
7.85
19-35
Male
675,112
95.64
2.01
9.62
Medication
37,518
Yes
62.14
4,181
5.4
66,035
0.75
84.16
UK
2,001
Asthma
Respiratory
15.09
1.39
5.28
19-35
Other
196,827
66.84
1.08
1.76
Surgery
44,835
No
52
2,761
8.41
97,683
0.88
66.41
France
2,012
Polio
Genetic
17.97
14.95
0.51
61+
Male
472,620
70.33
4.06
6.18
Vaccination
38,948
No
58.35
2,145
7.04
48,508
0.89
42.88
Italy
2,002
Hepatitis
Metabolic
11.27
14.1
6.54
61+
Other
411,017
97.91
2.91
6.25
Surgery
1,544
No
92.64
1,654
3.75
6,620
0.89
48.04
Russia
2,009
COVID-19
Respiratory
19.48
10.41
3.4
19-35
Male
929,016
97.88
0.86
6.51
Surgery
12,023
Yes
86.8
1,771
8.2
63,115
0.59
57.31
UK
2,008
Cancer
Bacterial
8.12
8.58
5.85
0-18
Male
432,506
57.81
0.79
6.69
Vaccination
40,742
No
97.46
812
9.21
5,939
0.41
32.76
Nigeria
2,003
Polio
Infectious
8.2
13.28
8.04
19-35
Male
197,972
56.79
2.71
6.53
Medication
27,625
No
63.55
1,881
4.38
2,347
0.45
68.52
Australia
2,013
Cancer
Cardiovascular
16.13
7.82
2.81
36-60
Male
75,709
99.72
3.31
9.49
Therapy
24,545
No
57.43
2,607
2.22
41,811
0.78
37.57
Canada
2,015
Cholera
Respiratory
0.2
12.46
0.62
19-35
Male
997,992
60.93
3.26
4.44
Therapy
10,376
Yes
93.68
2,406
4.59
72,805
0.74
22.52
UK
2,023
Polio
Bacterial
10.69
5.69
3.12
19-35
Male
55,467
53.02
3.58
2.32
Vaccination
10,052
No
71.01
959
5.57
87,935
0.64
89.02
South Africa
2,001
Dengue
Viral
5.36
12.16
1.15
36-60
Other
943,366
59.36
1.21
2.65
Therapy
19,131
Yes
86.17
456
6.91
77,661
0.83
39.8
USA
2,020
Influenza
Metabolic
8.06
0.4
2.78
61+
Male
871,292
60.95
2.81
8.16
Therapy
49,671
Yes
58.75
1,458
1.23
31,474
0.73
55.38
Argentina
2,012
Malaria
Genetic
2.71
10.97
5.68
19-35
Female
837,164
95.72
3.28
3.33
Surgery
26,506
Yes
89.14
2,779
6.35
56,606
0.49
67.91
Brazil
2,021
Malaria
Parasitic
12.12
4.91
5.55
0-18
Male
767,760
76.47
3.31
9.86
Vaccination
38,837
No
76.76
4,643
6.57
53,833
0.41
64.3
China
2,013
Cancer
Viral
15.57
4.01
4.44
36-60
Male
386,948
98.78
4.17
7.51
Medication
3,109
No
67.24
1,330
7.33
77,104
0.48
61.36
Brazil
2,009
Rabies
Autoimmune
4.96
5.73
6.74
61+
Male
468,156
80.73
4.03
9.4
Therapy
15,324
No
90.18
3,420
9.89
94,506
0.48
68.94
Russia
2,012
Asthma
Chronic
4.82
6.69
2.02
36-60
Female
695,608
86.77
1.97
7.3
Therapy
16,648
No
94.04
3,429
0.77
80,558
0.88
67.57